Home
Search
Schedule & Agenda

Cyclacel Pharmaceuticals, Inc.

[Available On-Demand]
June 8-12, 2020
Search
Event Menu
Event Menu
Search General Info
Search Education
Search Partnering Companies
Cyclacel is a clinical-stage biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation and DNA damage response biology.
Ticker:
CYCC; CYCCP
Exchange:
Nasdaq
Company Type:
Publicly Traded Company
Company Website:
www.cyclacel.com
Company HQ State:
New Jersey
Company HQ Country:
United States
Year Founded:
1997
Main Therapeutic Focus:
Oncology
Lead Product in Development:
Fadraciclib
Development Phase of Primary Product:
Phase I
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Spiro Rombotis, MPH, MBA
President and CEO
Cyclacel Pharmaceuticals, Inc.